Fox Chase Cancer Center Appoints New Chief Scientific Officer and Names New Executive Director of Institute for Personalized Medicine
PHILADELPHIA (August 5, 2010) – In an important step toward continuing its leadership in providing world-class care to current and future cancer patients and conducting leading-edge research, Fox Chase Cancer Center today appointed Jonathan Chernoff, MD, PhD, to the critical role of Chief Scientific Officer.